Stevens First Principles Investment Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-600
Closed -$63K 252
2014
Q2
$63K Buy
+600
New +$63K 0.03% 138